Your session is about to expire
← Back to Search
ACHIEVE Pilot Statins for Vascular Protection (ACHIEVE Trial)
N/A
Waitlist Available
Led By Christopher Granger, MD
Research Sponsored by Duke University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 2 years
Awards & highlights
No Placebo-Only Group
Summary
ACHIEVE aims to increase statin usage among patients with ASCVD by having a pharmacist talk to patients and providers.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 2 years
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~2 years
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Patient engagement as measured by recruitment
Provider engagement as measured by recruitment
Awards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
1Treatment groups
Experimental Treatment
Group I: No statinExperimental Treatment1 Intervention
Patients who are identified with ASCVD who do not take a statin or do not take the recommended dose.
Find a Location
Who is running the clinical trial?
Duke UniversityLead Sponsor
2,463 Previous Clinical Trials
2,981,322 Total Patients Enrolled
Harvard Pilgrim Health CareOTHER
59 Previous Clinical Trials
24,985,876 Total Patients Enrolled
Carelon ResearchOTHER
75 Previous Clinical Trials
124,469 Total Patients Enrolled
National Heart, Lung, and Blood Institute (NHLBI)NIH
3,944 Previous Clinical Trials
47,799,607 Total Patients Enrolled
Christopher Granger, MDPrincipal InvestigatorDuke University
4 Previous Clinical Trials
21,583 Total Patients Enrolled